Literature DB >> 20362713

Changes in beliefs about medications during long-term care for ischemic heart disease.

Nancy M Allen LaPointe1, Fang-Shu Ou, Sara B Calvert, Chiara Melloni, Judith A Stafford, Tina Harding, Karen P Alexander, Eric D Peterson.   

Abstract

BACKGROUND: Beliefs such as self-reported low necessity for medications and high concerns about medications are associated with nonadherence. Changes in these beliefs during long-term care have not previously been studied and were evaluated for purposes of this analysis.
METHODS: From January 2006 through September 2007, patients at 41 hospitals who met entry criteria for the CRUSADE Quality Improvement Initiative were consented for participation in a longitudinal follow-up survey study called MAINTAIN. The patients completed The Beliefs about Medicines Questionnaire at 3 and 12 months postdischarge to assess necessity and concerns related to heart medications. Internal reliability and construct validity of the survey were evaluated at both time points. Changes in necessity and concern scores from 3 to 12 months were determined, and factors associated with negative changes were explored.
RESULTS: A total of 812 patients completed both surveys. Internal reliability and construct validity were good. From 3 to 12 months, only 9.2% of patients shifted from a high to low necessity score; however, 20.7% of patients shifted from a low to high concern score. Factors found to be statistically significantly and independently associated with increased concern were the perception that the provider did not listen carefully to the patient (odds ratio [OR] 2.63, 95% CI 1.49-4.76), depression at 12 months (OR 2.95, 95% CI 1.57-5.55), hospital discharge with > or =7 medications (OR 1.71, 95% CI 1.07-2.74), and not receiving a medication list/instructions at hospital discharge (OR 1.69, 95% CI 1.05, 2.78). Factors associated with decreased necessity included not having a cardiologist (OR 2.26, 95% CI 1.34-3.83) and nonpersistence at 12 months with lipid-lowering medication (OR 1.85, 95% CI 1.01-3.45).
CONCLUSIONS: One third of the patients reported a negative change in their beliefs about heart medications. Although some changes were observed in perceived necessity, negative changes in concerns occurred in 1 of every 5 patients. Interventions that address these concerns may be useful in improving adherence and clinical outcomes. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20362713     DOI: 10.1016/j.ahj.2009.12.025

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Initiation of statin therapy after acute myocardial infarction is not associated with worsening depressive symptoms: insights from the Prospective Registry Evaluating Outcomes After Myocardial Infarctions: Events and Recovery (PREMIER) and Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) registries.

Authors:  Firas J Al Badarin; John A Spertus; Kensey L Gosch; Donna M Buchanan; Paul S Chan
Journal:  Am Heart J       Date:  2013-10-09       Impact factor: 4.749

2.  Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients.

Authors:  Benjamin Cassell; C Prakash Gyawali; Vladimir M Kushnir; Britt M Gott; Billy D Nix; Gregory S Sayuk
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

Review 3.  Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.

Authors:  Rob Horne; Sarah C E Chapman; Rhian Parham; Nick Freemantle; Alastair Forbes; Vanessa Cooper
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 4.  Evidence-based and pragmatic steps for pharmacists to improve patient adherence.

Authors:  Tommy Eriksson
Journal:  Integr Pharm Res Pract       Date:  2015-05-14

5.  Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers.

Authors:  Rani Khatib; Kay Marshall; Jon Silcock; Claire Forrest; Alistair S Hall
Journal:  Open Heart       Date:  2019-07-03

6.  Medication beliefs and use of medication lists - is there a connection? Results from a before-and-after study in Germany.

Authors:  Cornelia Straßner; Cornelia Mahler; Beate Strauß; Ulrich Wehrmann; Katja Krug; Joachim Szecsenyi; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  BMC Geriatr       Date:  2020-03-30       Impact factor: 3.921

7.  Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Intervention Development and Protocol for the Process Evaluation.

Authors:  Malin Johansson Östbring; Tommy Eriksson; Göran Petersson; Lina Hellström
Journal:  JMIR Res Protoc       Date:  2018-01-30

8.  Length of time periods in treatment effect descriptions and willingness to initiate preventive therapy: a randomised survey experiment.

Authors:  Erik Berglund; Ragnar Westerling; Johan Sundström; Per Lytsy
Journal:  BMC Med Inform Decis Mak       Date:  2018-11-20       Impact factor: 2.796

9.  Trivial or Troublesome: Experience with Coronary Heart Disease Medication from the Patient's Perspective.

Authors:  Malin Johansson Östbring; Lina Hellström; Jan Mårtensson
Journal:  Patient Prefer Adherence       Date:  2020-02-27       Impact factor: 2.711

10.  Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial.

Authors:  Malin Johansson Östbring; Tommy Eriksson; Göran Petersson; Lina Hellström
Journal:  BMC Cardiovasc Disord       Date:  2021-08-01       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.